Key Research Question: Antimicrobial Utilization in COVID-19 Patients for Suspected Coinfection or Superinfection [open pdf - 360KB]
From the Context: " Multiple jurisdictions are creating COVID-19 [coronavirus disease 2019] care pathways for patients in various care settings, many of which involve antibacterial therapy.  This review was requested to assess current data on the incidence of co-infections at presentation or bacterial or fungal superinfection that may influence guideline creation.  Literature on hospitalized patients with other viral respiratory tract infections suggests high rates of antimicrobial use without obvious benefit."
2020 Alberta Health Services. Posted here with permission. Document is under a Creative Commons license and requires proper attribution and noncommercial use to be shared: [https://creativecommons.org/licenses/by-nc-nd/4.0]
Alberta Health Services: https://www.albertahealthservices.ca/